Drug Information

Drug General Information
Drug ID
D0R3DP
Former ID
DNC013248
Drug Name
L-valyl-L-proline hexylamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C16H31N3O2
Canonical SMILES
CCCCCCNC(=O)C1CCCN1C(=O)C(C(C)C)N
InChI
1S/C16H31N3O2/c1-4-5-6-7-10-18-15(20)13-9-8-11-19(13)16(21)14(17)12(2)3/h12-14H,4-11,17H2,1-3H3,(H,18,20)/t13-,14-/m0/s1
InChIKey
BWJSLNXXZBEGLH-KBPBESRZSA-N
PubChem Compound ID
11623539
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.